Structured facts
{
"code": "A",
"date": "2025-09-16",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents 10,000 restricted stock units (\"RSUs\") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan (the \"Plan\"). The 10,000 RSUs were granted on September 16, 2024, in conjunction with the Issuer\u0027s initial public offering (IPO), and grant in substantially equal installments on the anniversary date of the IPO.",
"F2": "Consists of (i) 3,334 shares of common stock and (ii) 6,666 RSUs which remain subject to vesting."
},
"owners": [
{
"cik": "0001824764",
"name": "Keyoung Hansoo Michael",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "10000",
"price": "0.00",
"row": 1,
"rule_10b5_1": "0",
"security": "COMMON STOCK",
"shares": "10000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}